Insider transactions

Gary T Steele

CIK 1192863 · CEO and President · last filed 2018-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
54
Lifetime Open-Market Net
-$4.39M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

LNDC price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Director 103,076 $8.76 $902.9K -$4.39M 54 2018-06-01

Recent Filings · Page 4 of 6

54 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-10-11 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Mixed +10,277 $29.0K EDGAR
2010-12-13 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) +7,611 $0 EDGAR
2010-11-29 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) +34,514 -$124.8K EDGAR
2010-10-06 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Buy (P) +200 $1.2K EDGAR
2010-05-27 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) — $0 EDGAR
2010-03-25 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) — -$108.9K EDGAR
2010-03-23 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) −20,634 -$151.7K EDGAR
2010-03-11 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) −4,300 -$29.8K EDGAR
2010-03-09 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) −10,900 -$73.7K EDGAR
2010-03-09 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Exer (M) −34,800 -$241.1K EDGAR
Showing 31–40 of 54
Page 4 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.